Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial-Reference-Cited by-同舟云学术

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Published:2020-01 Issue:1 Volume:7 Page:e28-e39
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Beelen Dietrich Wilhelm,Trenschel Rudolf,Stelljes Matthias,Groth Christoph,Masszi Tamás,Reményi Péter,Wagner-Drouet Eva-Maria,Hauptrock Beate,Dreger Peter,Luft Thomas,Bethge Wolfgang,Vogel Wichard,Ciceri Fabio,Peccatori Jacopo,Stölzel Friedrich,Schetelig Johannes,Junghanß Christian,Grosse-Thie Christina,Michallet Mauricette,Labussiere-Wallet Hélène,Schaefer-Eckart Kerstin,Dressler Sabine,Grigoleit Goetz Ulrich,Mielke Stephan,Scheid Christof,Holtick Udo,Patriarca Francesca,Medeot Marta,Rambaldi Alessandro,Micò Maria Caterina,Niederwieser Dietger,Franke Georg-Nikolaus,Hilgendorf Inken,Winkelmann Nils Rudolf,Russo Domenico,Socié Gérard,Peffault de Latour Régis,Holler Ernst,Wolff Daniel,Glass Bertram,Casper Jochen,Wulf Gerald,Menzel Helge,Basara Nadezda,Bieniaszewska Maria,Stuhler Gernot,Verbeek Mareike,Grass Sandra,Iori Anna Paola,Finke Juergen,Benedetti Fabio,Pichlmeier Uwe,Hemmelmann Claudia,Tribanek Michael,Klein Anja,Mylius Heidrun Anke,Baumgart Joachim,Dzierzak-Mietla Monika,Markiewicz Miroslaw

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years;Cornelissen;Leukemia,2015

2. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel;de Witte;Blood,2017

3. One million haemopoietic stem-cell transplants: a retrospective observational study;Gratwohl;Lancet Haematol,2015

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

5. Revised International Prognostic Scoring System for myelodysplastic syndromes;Greenberg;Blood,2012

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients;Bone Marrow Transplantation;2024-09-02

2. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

3. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial;Blood Cancer Journal;2024-08-21

4. Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML;Cancers;2024-08-16

5. Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation;Transplantation and Cellular Therapy;2024-08